Basel, Switzerland

Franck Mallet

This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2017.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Franck Mallet: Innovator in Pharmaceutical Chemistry

Introduction

Franck Mallet is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for cancer treatment. His work exemplifies the intersection of science and innovation, leading to advancements that can potentially improve patient outcomes.

Latest Patents

Franck Mallet holds a patent for a compound titled "Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide." This invention relates to the particles of the compound, a process for making these particles, pharmaceutical compositions that include them, and methods for treating cancers using these compositions. His patent reflects a commitment to addressing critical health challenges through innovative solutions.

Career Highlights

Franck Mallet is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to work on groundbreaking research and development projects that aim to enhance therapeutic options for patients. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Franck has collaborated with esteemed colleagues, including Nicole Buschmann and Robin Alec Fairhurst. These collaborations have fostered a dynamic environment for innovation and have contributed to the advancement of their shared goals in pharmaceutical research.

Conclusion

Franck Mallet's contributions to pharmaceutical chemistry and his innovative patent demonstrate his dedication to improving cancer treatment options. His work at Novartis AG and collaborations with fellow researchers highlight the importance of teamwork in driving scientific advancements. Franck Mallet continues to be a significant figure in the field of pharmaceuticals, paving the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…